Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

被引：0
|
作者：
Nobuyuki Amemiya
Takashi Takei
Chiari Kojima
Hirohiko Nokiba
Mitsuyo Itabashi
Kosaku Nitta
机构：
[1] Tokyo Women’s Medical University,Department of Medicine, Kidney Center
来源：
Clinical and Experimental Nephrology | 2011年 / 15卷
关键词：
Frequently relapsing minimal change nephrotic syndrome; Rituximab; Monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Treatment with a single dose of rituximab alone induced remission in a patient with relapsed minimal change nephrotic syndrome (MCNS). A 27-year-old man was given corticosteroid (prednisolone; PSL) and cyclosporine (CyA) therapy combined with rituximab for his fifth relapse in 2008. Thereafter, complete remission was achieved and maintained despite eventual discontinuation of the PSL and CyA. In 2010, we treated his sixth relapse with a single dose of rituximab. Complete remission was obtained 32 days later. This is the first report of rituximab monotherapy in the treatment of MCNS.
引用
收藏
页码：933 / 936
页数：3
相关论文
共 50 条
  • [31] Minimal change nephrotic syndrome showing complete remission after resection of a neurofibroma in a type I neurofibromatosis patient
    Hyun, Ji In
    Min, Ji Won
    Lee, Hye Min
    Kim, Yong Kyun
    Choi, Eu Jin
    Song, Ho Cheol
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (01): : 186 - 189
  • [32] DNA methylation changes between relapse and remission of minimal change nephrotic syndrome
    Yasuko Kobayashi
    Akira Aizawa
    Takumi Takizawa
    Chikage Yoshizawa
    Hiromi Horiguchi
    Yuka Ikeuchi
    Satoko Kakegawa
    Toshio Watanabe
    Kenichi Maruyama
    Akihiro Morikawa
    Izuho Hatada
    Hirokazu Arakawa
    Pediatric Nephrology, 2012, 27 : 2233 - 2241
  • [33] The patient with over 100 relapses of minimal change nephrotic syndrome:: prolonged complete remission after chlorambucil treatment
    Carreño, A
    Morales, E
    Domínguez-Gil, B
    Herrero, JC
    Ortiz, M
    González, E
    Praga, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (06) : 922 - 923
  • [34] Primary cutaneous cryptococcosis in a patient with minimal change nephrotic syndrome
    Ogami, N
    Horino, T
    Arii, K
    Takao, T
    Hashimoto, K
    Seike, M
    Kodama, H
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (11) : 2578 - 2579
  • [35] REMISSION OF THE NEPHROTIC SYNDROME WITH MINIMAL CHANGES WITH SPIRONOLACTONE
    MARCOFRANCO, JE
    ALARCONZURITA, A
    PIZABUNOLA, C
    MOREYMOLINA, A
    BALLESTEROSFERNANDEZ, A
    REVISTA CLINICA ESPANOLA, 1979, 155 (01): : 63 - 66
  • [36] Analysis Of Single Nucleotide Polymorphisms In Minimal Change Nephrotic Syndrome
    Suvanto, Maija
    Jahnukainen, Timo
    Kestila, Marjo
    Jalanko, Hannu
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1738 - 1738
  • [37] Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study
    Kim, Yong Chul
    Lee, Tae Woo
    Lee, Hajeong
    Koo, Ho Suk
    Oh, Kook-Hwan
    Joo, Kwon Wook
    Kim, Suhnggwon
    Chin, Ho Jun
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2012, 31 (02) : 112 - 117
  • [38] Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab
    Fujimoto, Keiji
    Kagaya, Yu
    Kumano, Syo
    Fujii, Ai
    Tsuruyama, Yuko
    Matsuura, Toshikazu
    Yamazaki, Keita
    Nomura, Kanae
    Okada, Keiichiro
    Okino, Kazuaki
    Adachi, Hiroki
    Furuichi, Kengo
    Yokoyama, Hitoshi
    CLINICAL NEPHROLOGY, 2021, 95 (01) : 29 - 36
  • [39] TREATMENT OF MINIMAL CHANGE NEPHROTIC SYNDROME WITH LOW-DOSE HYDROCORTISONE
    SCHOENEMAN, MJ
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 135 - 135
  • [40] Rituximab as a Therapeutic Option for Steroid-Sensitive Minimal Change Nephrotic Syndrome in Adults
    Iwabuchi, Yuko
    Moriyama, Takahito
    Itabashi, Mitsuyo
    Takei, Takashi
    Nitta, Kosaku
    RECENT ADVANCES IN THE PATHOGENESIS AND TREATMENT OF KIDNEY DISEASES, 2018, 195 : 12 - 19
12345